Carisma Therapeutics Inc. (CARM)
NASDAQ: CARM
· Real-Time Price · USD
0.45
-0.05 (-10.41%)
At close: Jun 20, 2025, 3:59 PM
Carisma Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -9.27M | -17.64M | -12.7M | -11.16M | -18.98M | -20.96M | -21.4M | -19.88M | -24.64M | -7.57M | -18.33M | -14.85M | -11.31M | 8.94M | 71.62M | -25.44M | -55.51M |
Depreciation & Amortization | 661K | 669K | 737K | 255K | 1.69M | 2.08M | 695K | 715K | 705K | 705K | 725K | 245K | 218K | 11K | 10K | 34K | 30K |
Stock-Based Compensation | 508K | 852K | 1.11M | 625K | 1.06M | 873K | 848K | 330K | 265K | 40K | 88K | 58K | 89K | 118K | 102K | 129.5K | 129.5K |
Other Working Capital | n/a | 7.63M | -2.81M | -8.89M | -6.03M | 271K | -2.11M | 1.47M | -7.26M | -4.07M | 783K | -765K | 21.38M | 5.73M | -9.09M | -12.4M | -8.13M |
Other Non-Cash Items | n/a | -245K | 963K | 4.34M | 1.66M | 2.89M | 1.43M | 1.38M | 2.57M | -14.06M | 2.14M | 2.01M | 1.62M | 21.62M | -84.94M | 15.12M | 53.16M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -3.22M | -172K | -406K | n/a | 13.45M | 668K | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 8.01M | -3.13M | -8.97M | -7.86M | 2.09M | -2.4M | -691K | -4.44M | 10.12M | 6.39M | -1.76M | 43.99M | -18.71M | -5.21M | -12.59M | -12.11M |
Operating Cash Flow | -10.07M | -8.35M | -13.02M | -16.12M | -22.43M | -16.24M | -21M | -18.55M | -25.53M | 2.68M | -8.32M | -14.3M | 34.6M | -12.6M | -14.66M | -23.14M | -18.48M |
Capital Expenditures | n/a | n/a | 12K | -106K | -17K | -561K | -189K | -247K | -135K | -319K | -2.3M | -1.03M | -1.01M | -345K | 45K | -49K | -500.5K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -3.46M | n/a | n/a | 3.46M | -13.81M | -42M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | 49.7M | n/a | n/a | n/a | n/a | n/a | -34.46M | -15.24M | -41.92M | 21.14M | -63.24M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 31.07M | -31.07M | n/a | n/a | 11M | 30M | 36M | 31M | 75M | 42M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 524K | n/a | -74.92M | n/a | n/a | 11M | 30M | 36M | -3.46M | 14.13M | 42M | 21.14M | -63.24M | n/a | n/a | -49K | n/a |
Investing Cash Flow | 524K | 56.29M | -56.29M | -106K | -17K | 10.44M | 29.81M | 35.75M | -3.6M | 59.76M | -2.23M | 20.11M | -64.25M | -345K | 45K | -49K | -500.5K |
Debt Repayment | n/a | -271K | -252K | 413K | -1.32M | n/a | -938K | -107K | -106K | n/a | -749K | -17K | 35M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5K | -326K | -338K | -342K | 2.67M | 101K | -1.09M | -3.52M | 37.21M | 1K | 543K | n/a | n/a | n/a | n/a | 64.26M | 73.05M |
Financial Cash Flow | -626K | -620K | -461K | 73K | 1.35M | 247K | -2.03M | -3.63M | 67.74M | 1K | -208K | -15K | 35M | 1K | 38.82M | 64.26M | 73.05M |
Net Cash Flow | -10.17M | -8.97M | -13.48M | -16.15M | -21.09M | -5.53M | 6.78M | 13.58M | 38.61M | 62.45M | -10.76M | 5.79M | 5.35M | -12.6M | 127.05M | 41.05M | 54.56M |
Free Cash Flow | -10.07M | -8.35M | -13.02M | -16.23M | -22.44M | -16.8M | -21.19M | -18.79M | -25.67M | 2.36M | -10.62M | -15.33M | 33.6M | -12.95M | -14.62M | -23.19M | -18.98M |